Life Sciences
Alston & Bird is committed to supporting the life sciences industry’s phenomenal growth and to ensuring that leading scientific research is rapidly translated into real-world innovation and commercialization. As a firm, we have assembled a team with legal talent and scientific proficiency to address our clients’ legal needs, whether those needs relate to intellectual property procurement or enforcement, regulatory compliance, import-export issues, trade regulation, products liability and commercial litigation, public or private equity and debt financing, mergers and acquisitions, strategic alliances or other transactional matters. We possess the necessary legal skills, coupled with an understanding of the life sciences industry, to provide comprehensive legal services, solid business counseling and creative strategic thinking. We understand how the multidisciplinary aspects of the law and science must fit together.
Our client base extends across the United States to Europe, South America and Asia and includes emerging and established biotechnology companies, pharmaceutical and drug delivery companies, nationally acclaimed research centers and universities, health services organizations, medical device companies, investment banking and private equity and venture capital firms targeting life science companies.
EXPERIENCE
Our multidisciplinary group provides key legal services related to the particular needs of businesses competing in the life sciences industry.
WHERE LAW AND SCIENCE CONNECT®
The diversity in our experience and technical training in areas of critical importance to life sciences companies distinguishes Alston & Bird from other law firms. Our life sciences practice includes members who collectively hold more than 30 life sciences degrees in all the major fields of biology as well as in chemistry, chemical engineering and biomedical engineering, 11 of which are doctorates. We bring a depth of knowledge and expertise in a variety of fields, including pharmacology, biotechnology, genomics, proteomics, therapeutics and drug delivery, medical devices and nanotechnology, and in other chemical, agricultural and health care science areas. Our life sciences clients range from some of the largest biotechnology and pharmaceutical companies in the world to cutting-edge startup companies and also include major medical device companies and world-class research universities.
RECOGNITION
Our life sciences team members include former U.S. Senate majority leaders Senator Bob Dole and Senator Tom Daschle, a former CMS administrator, a former associate FDA commissioner and a former associate chief counsel for Enforcement at FDA. Twelve members of the team are listed in The Best Lawyers in America. Our team also includes the current co-chairman of the American Bar Association’s Committee on Food and Drug Law, a member of the National Advocacy Council for the CDC Foundation, Inc., and an executive board member of the Southeast BIO Organization.
WHY ALSTON & BIRD?
The life sciences industry continues to expand exponentially. As the science and technology become more sophisticated and complex, so do the legal challenges faced by the industry. Alston & Bird is prepared to be the law firm of choice to life sciences industry companies. Alston & Bird is Where Law and Science Connect.®